Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC in Onychophagia
NCT01993849Phase 3Completed
- Start
- Oct 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in onychophagia. Started Oct 2013; status: completed.
02
Drugs
acetylcysteine
03
Conditions
onychophagia
Beyond the preview
Go deeper on NCT01993849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993849.